ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.22
-0.93%
US Tech 100
18,488.00
-0.25%
S&P 500
5,346.99
-0.11%
US Dollar vs CAD
1.37725
-0.03%
Bitcoin
69,412.46
0.12%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Tyra Biosciences Inc (TYRA)

  7. Tyra Biosciences Inc (TYRA) News

TYRA

Tyra Biosciences (TYRA)

Tyra Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TYRA
DateTimeSourceHeadlineSymbolCompany
06/07/20242:08PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TYRATyra Biosciences Inc
05/31/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
05/31/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
05/31/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TYRATyra Biosciences Inc
05/23/20243:05PMPR Newswire (US)Tyra Biosciences to Present at Upcoming Investor ConferencesNASDAQ:TYRATyra Biosciences Inc
05/09/20243:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
05/09/20243:46PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
05/09/20243:12PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TYRATyra Biosciences Inc
05/09/20243:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TYRATyra Biosciences Inc
05/09/20243:05PMPR Newswire (US)Tyra Biosciences Reports First Quarter 2024 Financial Results and HighlightsNASDAQ:TYRATyra Biosciences Inc
05/07/20243:34PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TYRATyra Biosciences Inc
05/07/20243:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TYRATyra Biosciences Inc
05/07/20243:05PMPR Newswire (US)Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of DirectorsNASDAQ:TYRATyra Biosciences Inc
03/19/20243:05PMPR Newswire (US)Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and HighlightsNASDAQ:TYRATyra Biosciences Inc
03/08/20244:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
03/05/20244:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
02/29/20245:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
02/27/20243:05PMPR Newswire (US)Tyra Biosciences to Present at Upcoming Investor ConferencesNASDAQ:TYRATyra Biosciences Inc
02/14/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
02/13/20243:36PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:TYRATyra Biosciences Inc
02/12/20243:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TYRATyra Biosciences Inc
02/09/20246:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
02/07/20243:05PMPR Newswire (US)Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences ConferenceNASDAQ:TYRATyra Biosciences Inc
02/06/20247:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
02/06/20243:56PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TYRATyra Biosciences Inc
02/05/20245:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TYRATyra Biosciences Inc
02/02/20244:04PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TYRATyra Biosciences Inc
02/02/20247:00AMPR Newswire (US)Tyra Biosciences, Inc. Announces $200 Million Private Placement FinancingNASDAQ:TYRATyra Biosciences Inc
02/01/20244:30PMPR Newswire (US)Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of AchondroplasiaNASDAQ:TYRATyra Biosciences Inc
02/01/20244:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TYRATyra Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:TYRA

Your Recent History

NASDAQ
AAYZMXX
Hsbc Usa Inc Autocallabl...
EU
SFCAF
Societe Generale SCF Bon...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved